Demographics of study participants in each study group
| EBUS first | PETCT first | |
| Subjects n | 107 | 107 |
| Age years | 70.0±10.1 | 70.0±10.6 |
| Male sex | 59 (55.1) | 49 (45.8) |
| Ever smoker | 94 (87.9) | 92 (86.0) |
| Lymph node stations sampled n | 3±1.2 | 3±1.4 |
| Interval between tests days | 11.6±6.8 | 11.0±8.7 |
| Final diagnosis | ||
| Nonsmall cell lung cancer | 93 (86.9) | 90 (84.1) |
| Small cell lung cancer | 7 (6.5) | 8 (7.5%) |
| Other malignancy | 7 (6.5) | 9 (8.4%) |
| Cancer stage | ||
| I | 17 (15.9) | 33 (30.8) |
| II | 14 (13.1) | 18 (16.8) |
| III | 44 (41.1) | 31 (29.0) |
| IV | 32 (29.9) | 25 (23.4) |
Data are presented as mean±sd or n (%), unless otherwise stated. EBUS: endobronchial ultrasound; PETCT: positron emission tomography–computed tomography.